Cardiac Monitoring & Cardiac Rhythm Management Devices Market Worth 28.00 Billion USD by 2021

Friday, November 18, 2016 Heart Disease News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, November 18, 2016 /PRNewswire/ --

According to a new market research report "Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM [ECG (Resting, Stress, Holter Monitor), COM Devices, Implantable Loop Recorders, Event Monitors], CRM (Defibrillators (ICDs, External), Pacemakers, CRT-D, CRT-P) - Global Forecast to 2021

" published by MarketsandMarkets, the global market is projected to reach USD 28.00 Billion by 2021 from USD 22.19 Billion in 2016, at a CAGR of 4.8% from 2016 to 2021.

     (Logo: )

Browse 176 market data Tables and 33 Figures spread through 184 Pages and in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management Devices Market"

Early buyers will receive 10% customization on this report. 

This report provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with estimates and forecast of revenue. Factors such as increasing incidence of cardiovascular diseases, technological advancements, and rise in private institutional nursing and home care are driving the CM & CRM Devices Market. However, dearth of skilled healthcare professionals with expertise in electrocardiography and cardiac monitoring and limited reimbursements for remote cardiac monitoring devices are major factors restraining the growth of the CM & CRM Devices Market.

Speak to our research experts:

The market is segmented on the basis of product, end user, and region. On the basis of product, the CM devices market is segmented into ECG devices, implantable loop recorder (ILR), and cardiac output monitoring (COM) devices, and event monitors. The ECG devices segment is the largest and fastest-growing product segment due to increasing incidence of cardiovascular diseases.

On the basis of product, the CRM devices market is segmented into defibrillators, pacemakers, and cardiac resynchronization therapy (CRT) devices. The defibrillators segment is the largest and fastest-growing segment.

On the basis of end user, the market is segmented into home and ambulatory care, hospitals, and other end users (research institutes and laboratories). The home and ambulatory care segment is expected to account for the largest share of the market in 2016.

On the basis of region, the CM & CRM Devices Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2015, North America accounted for the largest share of the CM & CRM Devices Market, followed by Europe. However, Asia is expected to account for the largest share during the forecast period. The growth of the CM & CRM Devices Market in the Asia will revolve around China, India, and Japan.

Major players operating in the CM & CRM Devices Market are Medtronic plc (Ireland), GE Healthcare (U.S.), Boston Scientific Corporation (U.S.), Philips Healthcare (Netherlands), and St. Jude Medical, Inc. (U.S.)

Browse Related Reports: 

Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospital, Prehospital, Public Access, Home) - Global Forecasts to 2021

Patient Monitoring Device/Equipment/System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Ultiparameter, Remote, Weight, Temperature), End-User (Hospitals, Home) - Global Forecast to 2020   About MarketsandMarkets:

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Contact: Mr. Rohan MarketsandMarkets 701 Pike Street, Suite 2175, Seattle, WA 98101, United States 1-888-600-6441 Email:

Visit MarketsandMarkets Blog @

Connect with us on LinkedIn @

SOURCE MarketsandMarkets


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store